Evidence map›Paper›PMID 41857761›Full record

ArticleBMC health services research2026

The differential impact of Diagnosis-Related Groups (DRG) on hierarchical hospitals: an interrupted time series analysis on health expenditure structure.

Shulei Li, Lang Tu, Ruoxi Fan, Xiaoyuan Zhou

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shulei LiWest China School of Public Health/ West China Fourth Hospital, Sichuan University, Chengdu, 610041, China.
Lang TuWest China School of Public Health/ West China Fourth Hospital, Sichuan University, Chengdu, 610041, China.
Ruoxi FanWest China School of Public Health/ West China Fourth Hospital, Sichuan University, Chengdu, 610041, China.
Xiaoyuan ZhouWest China School of Public Health/ West China Fourth Hospital, Sichuan University, Chengdu, 610041, China. zhouxyuan@scu.edu.cn.

Funding

National Key Research and Development Program of China No. 2020YFC2006500 & 2020YFC2006503Sichuan Hospital Association No. SQBX-2023-1105
6 · The paper itself

Abstract

backgroundSince the establishment of the National Healthcare Security Administration, China has been actively advancing DRG (Diagnosis-Related Group) reform to address issues related to healthcare fund management and patients’ burden. City C, a major city in southwest China, officially implemented the DRG payment reform in January 2021. The objective of this study is to investigate the changes in hospitalization costs and their structure after the DRG payment reform, providing empirical evidence to optimize health insurance payment policies.

methodsUsing 60,176 valid cases in 62 secondary hospitals and 172,564 valid cases in 52 tertiary hospitals from 2018 to 2021, data were extracted from the local official health insurance platform. An interrupted time series analysis (ITSA) model was employed, with average of hospitalization costs, five cost categories (drug costs, examination costs, etc.), and their respective proportions as the study variables to compare changes before and after the reform.

resultsFollowing the DRG reform, average of hospitalization costs showed an immediate decline of $73.74 in secondary hospitals and $143.59 in tertiary hospitals, with both maintaining downward trends. Cost control was observed in examination costs and material costs in secondary hospitals, and in drug costs and examination costs in tertiary hospitals (P < 0.05). Structurally, there have been few changes in secondary hospitals following DRG reform, but in tertiary hospitals, the proportion of drug costs declined by 2.09% during the 11-month post-reform observation period, while material and treatment costs increased by 1.76% and 2.09% respectively. In addition, heterogeneity tests confirmed that tertiary hospitals achieved greater reductions in drug costs and exhibited more pronounced structural adjustments.

conclusionsWhile the hospitalization costs have been significantly controlled following the DRG reform, structural optimization was insufficient and its impact varied by hospital grades. Further deepening of the reform is necessary, with an emphasis on strengthening policy regulation and implementing differentiated strategies to achieve synergistic improvement in cost control and structural optimization. CLINICAL TRAIL NUMBER: Not applicable

Indexed as

Diagnosis-Related GroupsHealth ExpendituresHospital CostsHospitalizationChinaHealth Care ReformHumansInterrupted Time Series AnalysisCost structureDiagnosis-related groupHierarchical hospitalsHospitalization costsInterrupted time series analysis

Identifiers

PMID41857761
PMCPMC13123101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.